Submissions

Call for papers

Advances in Metabolic Health (AMH)

Submissions are usually acknowledged within 2 weeks of receipt. AMH cannot accept responsibility for lost or mislaid manuscripts. Keep original copies in your possession. Upon receipt you will be notified of the acceptance for peer review. You will then be notified of all processing and publication fees. Two or more authorities will judge the validity, originality, and significance of the work presented. After the manuscript has been reviewed, the corresponding author will be informed whether it has been accepted for publication, rejected, or requires revision. Authors will be asked to transfer copyright to AMH when their manuscripts are accepted for publication. Accepted manuscripts become the property of AMH and may not be published or be made available online without written permission. If possible, please use MS Word for PC or Mac. All accepted manuscripts are subject to editing to conform to the American Medical Association Manual of Style, 11th edition, as well as accepted journalistic standards. Authors will be asked to review galleys after copy-editing and before publication. Upon approval manuscripts will be e-published ahead of print. Once e-published the manuscript will be selected in a future print issue based on topical fit in the editorial calendar at the digression of the editors, oldest articles are published first. All articles are published open access.

Article Processing Fee (APC)

All articles published in Advances in Metabolic Health (AMH) are subject to payment of an article processing charge (APC) in full open access. An article processing charge (APC) of $1500.00 (US Dollars) applies to papers accepted after peer review. This article processing charge is to cover the costs of peer review, copyediting, typesetting, long-term archiving, and journal management. Once accepted, you’ll receive an invoice that can be paid by credit card, bank transfer, or through institutional channels. Only official invoices issued by InnoVision Professional Media are valid. We do not authorize any third party to collect the APCs. InnoVision Professional Media is the sole service provider and cannot be held liable for actions by third parties.

Your article may be eligible for a full or partial waiver due to our participation in initiatives to increase accessibility to publication across the international academic community.

To submit to the journal, e-mail an electronic version to mary@innovisionhm.com and explain why this journal should publish your paper or use the form at the bottom of this page.

Please include the following:

Title of manuscript
Running title
All author’s full names in publishing order, with degrees, ranks, credentials, and affiliations
Name, address, telephone (home and work) and fax numbers, and e-mail address of corresponding author
Current mailing and e-mail addresses for all authors
If appropriate, institution(s) in which the work was presented
Key words
If appropriate, number or name of grant or information about other financial support used to write the article
Abstract (double-spaced on a separate page) Please use the following PRISMA checklist
Text (double-spaced, starting on a new page)
References (double-spaced, starting on a new page)
Tables and figures (starting on a new page do not integrate into electronic text; they must be separate files on disk)
Illustrations, original prints only, properly labeled
Copies of all signed permissions
Acknowledgments

Please download and complete our COI and Copyright forms

AMH CONFLICT OF INTEREST DISCLOSURE FORM

Types of Manuscripts to Submit

Visit our manuscript guidelines page for specific information for each article type. Here is a quick summary of article types we consider for publication.

Peer-Reviewed Submissions

Original Research Manuscripts

Original Research
Randomized controlled trials (RCTs)
Brief Reports
Pilot Studies

Review and Syntheses Manuscripts

Narrative/ Literature Reviews
Meta-analysis
Systematic Review

Clinical and Educational Content

Case Reports
Case Series

Non–Peer Reviewed Submissions

Commentary and Opinion

Editorials
Perspectives/ Viewpoints
Letters to the Editor
Author Reply Letters
Book Reviews

Manuscript Formatting And Other Details

Manuscript Content
Your manuscript should be formatted according to the International Committee of Medical Journal Editors (ICMJE). You may also find the Consolidated Standards of Reporting Trials (CONSORT) statement helpful for describing a randomized, controlled trial.

Authorship
Disputes over authorship, and multiauthorship in particular, are better resolved early on, preferably before a study begins. The author who is designated as “corresponding author” when the manuscript is submitted will be asked to approve editorial changes to the article on behalf of all authors prior to publication of the article. For more information please visit our Publication Ethics Page.

Ethics
When human experimentation is being reported, include a statement to confirm that the work was done in accordance with the appropriate institutional review body and carried out with the ethical standards set forth in the Helsinki Declaration of 2024. When laboratory animals are used, there should be a statement that the work was carried out according to the National Research Council’s protocol for, or any national law on, the care and use of laboratory animals. For more information please visit our Publication Ethics Page.

Abstracts
Abstracts should be up to 350 words for original research and reviews and are used to summarize the paper. Abstracts are not required for hypotheses, research letters, case reports, editorials, columns or commentaries, book reviews, or other intermittent special publications. Abstracts for original research and reviews should include the following headings whenever possible: Background/Context, Objective, Methods/Design, Setting, Participants, Interventions, Primary Outcome Measures, Results, Conclusions, and Trial Registry information. Please use the following PRISMA checklist. The structure for abstracts is as follows:

Background: One or two sentences explaining why this study is necessary and important.
Primary Study Objective: What are the primary study objectives?
Methods/Design: Outline the key elements of the study design, including a sample size calculation.
Setting: Where the study was done (how many sites, what kind of sites, etc).
Participants: Who participated in the study as well as their key demographic characteristics, the dropout rate, adverse events, etc.
Intervention: The key features of the intervention must be described. Trademarked product name once each in the abstract and body of the text.
Primary Outcome Measures: What outcome measures were used to measure the primary study objectives. These should be specified in advance (in the trial registry, for example).
Results: The results of the primary outcomes of the study, such as risk, confidence intervals, numbers needed to treat, or P-values, should be quantified and reported.
Conclusion: Conclusions supported by the results should be discussed as well as the clinical implications.

References
Start references on a separate page following the text, and number them consecutively in the text by order of appearance. In the text, designate reference numbers either as superscript or on the line in parentheses. (Do not use the footnote or endnote function in Word.) Abbreviate journal titles according to NLM Catalog/PubMed. If in doubt, cite complete journal name. Follow the format and punctuation set forth in the AMA Manual of Style, 11th ed, as illustrated in the following examples. Do not use periods in abbreviations of journal titles. List all authors, but if the number exceeds 6, list the first 3 names followed by “et al.”

Journal article: Pert CB, Dreher HE, Ruff MR. The psychosomatic network: foundations of mind-body medicine. Altern Ther Health Med. 1998;4(4):30-41.
Book chapter: Schiffman JD. Immunology of influenza. In: Cane MB, ed. Viruses and Influenza. Orlando, Fla: Academic Press; 1990:191-196.
Book: Avery GB. Neonatology: Pathophysiology and Management of the Neonate. 3rd ed. Philadelphia, Pa: JB Lippincott; 1987:77-80.

Tables
Number and title tables consecutively in the order in which they are mentioned in the text. Each column within a table should have a heading. Define abbreviations in the legend.

Figures
If you are unable to submit figures electronically, submit 1 copy by post. On the back of the copy note the figure number, last name of the primary author, and orientation (top/left/right). Include the name of the photographer or illustrator, if applicable. In clinical photographs in which the patient can be recognized, include a release signed by the patient or guardian granting permission to publish the photograph. If permission is not obtained, the photograph will be edited to ensure anonymity.

Permissions
If any material in the manuscript is from a prior copyrighted publication, a letter of permission from the copyright holder to reproduce the material should be included. If a photo or illustration does not belong to the author, it must be accompanied by a letter of permission from the copyright holder to reproduce it. Those cited in personal communications (verbal or written) also must grant the author written permission for the use of their names and/or material. For more information please visit our Publication Ethics Page.

Proprietary Interest
All authors must submit a completed and signed Conflict of Interest Disclosure Form disclosing any financial or proprietary interest in the subject matter or materials discussed (eg, employment, stock ownership, honoraria, etc). Manuscripts will not be accepted unless all authors have completed and submitted this form.

Drug Names
Use full generic names only, including inactive moiety. The trade name of a drug may be cited in parentheses the first time the generic name appears.

Abbreviations and Symbols
With the exception of standard units of measurements, avoid abbreviations. Do not use abbreviations in the title or abstract. When using a large number of abbreviations, list them in a table.

Reprints
Upon publication, authors will receive 2 complimentary copies of the issue in which their article appears. If you wish to purchase additional copies or reprints, notify the managing editor when you grant final approval of your edited article.

Timeliness and/or Publication Volume

Advances in Metabolic Health publishes one volume per calendar year, which consists of six bimonthly issues. We maintain a publication volume of 45-60 scholarly papers annually. This output reliably represents the full breadth of our scope in integrating alternative therapies with conventional medicine while maintaining rigorous, COPE-aligned peer review standards.

Submitting Manuscripts/Manuscript Processing

Please visit our publishing process page for complete information on our publishing process, here is a general outline.

Peer Review
Revisions
Decision
Accepted Manuscripts / Rejected Manuscripts
Publication